UniProt ID | ENR1_HUMAN | |
---|---|---|
UniProt AC | Q14264 | |
Protein Name | Endogenous retrovirus group 3 member 1 Env polyprotein | |
Gene Name | ERV3-1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 604 | |
Subcellular Localization | Virion. | |
Protein Description | Retroviral envelope proteins mediate receptor recognition and membrane fusion during early infection. Endogenous envelope proteins may have kept, lost or modified their original function during evolution. This endogenous envelope protein has lost its fusogenic properties. It can inhibit cell growth through decrease expression of cyclin B1 and increased expression of p21 in vitro.; SU mediates receptor recognition.; TM anchors the envelope heterodimer to the viral membrane through one transmembrane domain. The other hydrophobic domain, called fusion peptide, mediates fusion of the viral membrane with the target cell membrane (By similarity).. | |
Protein Sequence | MLGMNMLLITLFLLLPLSMLKGEPWEGCLHCTHTTWSGNIMTKTLLYHTYYECAGTCLGTCTHNQTTYSVCDPGRGQPYVCYDPKSSPGTWFEIHVGSKEGDLLNQTKVFPSGKDVVSLYFDVCQIVSMGSLFPVIFSSMEYYSSCHKNRYAHPACSTDSPVTTCWDCTTWSTNQQSLGPIMLTKIPLEPDCKTSTCNSVNLTILEPDQPIWTTGLKAPLGARVSGEEIGPGAYVYLYIIKKTRTRSTQQFRVFESFYEHVNQKLPEPPPLASNLFAQLAENIASSLHVASCYVCGGMNMGDQWPWEARELMPQDNFTLTASSLEPAPSSQSIWFLKTSIIGKFCIARWGKAFTDPVGELTCLGQQYYNETLGKTLWRGKSNNSESPHPSPFSRFPSLNHSWYQLEAPNTWQAPSGLYWICGPQAYRQLPAKWSGACVLGTIRPSFFLMPLKQGEALGYPIYDETKRKSKRGITIGDWKDNEWPPERIIQYYGPATWAEDGMWGYRTPVYMLNRIIRLQAVLEIITNETAGALNLLAQQATKMRNVIYQNRLALDYLLAQEEGVCGKFNLTNCCLELDDEGKVIKEITAKIQKLAHIPVQTWKG | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
10 | Phosphorylation | GMNMLLITLFLLLPL CHHHHHHHHHHHHHH | 16.07 | 24043423 | |
18 | Phosphorylation | LFLLLPLSMLKGEPW HHHHHHHHHHCCCCC | 21.82 | 24043423 | |
64 | N-linked_Glycosylation | CLGTCTHNQTTYSVC EEEECCCCCEEEEEE | 23.81 | UniProtKB CARBOHYD | |
105 | N-linked_Glycosylation | SKEGDLLNQTKVFPS CCCCCCCCEEEEECC | 55.56 | UniProtKB CARBOHYD | |
201 | N-linked_Glycosylation | TSTCNSVNLTILEPD CCCCCCEEEEEECCC | 31.15 | UniProtKB CARBOHYD | |
316 | N-linked_Glycosylation | RELMPQDNFTLTASS HHHCCCCCEEEEECC | 26.93 | UniProtKB CARBOHYD | |
338 | Phosphorylation | QSIWFLKTSIIGKFC CCEEEEEHHHHHHHH | 27.57 | 26270265 | |
339 | Phosphorylation | SIWFLKTSIIGKFCI CEEEEEHHHHHHHHH | 15.60 | 26270265 | |
369 | N-linked_Glycosylation | CLGQQYYNETLGKTL ECCHHHHHCCCCCCC | 30.73 | UniProtKB CARBOHYD | |
382 | N-linked_Glycosylation | TLWRGKSNNSESPHP CCCCCCCCCCCCCCC | 60.58 | UniProtKB CARBOHYD | |
399 | N-linked_Glycosylation | FSRFPSLNHSWYQLE CCCCCCCCCEEEECC | 31.33 | UniProtKB CARBOHYD | |
441 | Phosphorylation | SGACVLGTIRPSFFL CCCEEECCCCCCEEE | 15.06 | 17287340 | |
527 | N-linked_Glycosylation | AVLEIITNETAGALN HHHHHHHCCCHHHHH | 33.92 | UniProtKB CARBOHYD | |
569 | N-linked_Glycosylation | EGVCGKFNLTNCCLE CCCCCCCCCCCCEEE | 49.82 | UniProtKB CARBOHYD |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ENR1_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ENR1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ENR1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
Oops, there are no PPI records of ENR1_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-441, AND MASSSPECTROMETRY. |